Anchor Capital Advisors LLC Pfizer Inc Transaction History

Anchor Capital Advisors LLC

$3.51 Billion
Q3 2024

A detailed history of Anchor Capital Advisors LLC transactions in Pfizer Inc stock. As of the latest transaction made, Anchor Capital Advisors LLC holds 11,596 shares of PFE stock, worth $318,426. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,596

Previous 14,466 19.84%

Holding current value

$318,426

Previous $404,000 17.08%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$27.7 - $31.39 $79,499 - $90,089	-2,870 Reduced 19.84%	11,596 $335,000
Q2 2024 Aug 06, 2024	SELL	$25.26 - $29.6 $21,218 - $24,864	-840 Reduced 5.49%	14,466 $404,000
Q1 2024 May 07, 2024	SELL	$25.89 - $29.73 $146,666 - $168,420	-5,665 Reduced 27.01%	15,306 $424,000
Q4 2023 Feb 05, 2024	SELL	$26.13 - $33.94 $46,511 - $60,413	-1,780 Reduced 7.82%	20,971 $603,000
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $4,813 - $5,626	-150 Reduced 0.65%	22,751 $754,000
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $53,457 - $61,849	-1,480 Reduced 6.07%	22,901 $840,000
Q1 2023 May 03, 2023	SELL	$39.39 - $51.28 $38,602 - $50,254	-980 Reduced 3.86%	24,381 $994,000
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $208 - $272	-5 Reduced 0.02%	25,361 $1.3 Million
Q3 2022 Nov 09, 2022	SELL	$43.76 - $53.42 $8,314 - $10,149	-190 Reduced 0.74%	25,366 $1.11 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $190,075 - $225,369	-4,085 Reduced 13.78%	25,556 $1.34 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $94,245 - $116,781	-2,060 Reduced 6.5%	29,641 $1.54 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $71,277 - $105,656	-1,725 Reduced 5.16%	31,701 $1.87 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $58,247 - $74,823	-1,484 Reduced 4.25%	33,426 $1.44 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $14 Million - $15.8 Million	-389,251 Reduced 91.77%	34,910 $1.37 Million
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $703,725 - $793,661	21,013 Added 5.21%	424,161 $15.4 Million
Q4 2020 Feb 08, 2021	BUY	$33.47 - $42.56 $38,490 - $48,944	1,150 Added 0.29%	403,148 $14.8 Million
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $198,247 - $232,589	6,244 Added 1.58%	401,998 $14.8 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $190,328 - $230,896	-6,319 Reduced 1.57%	395,754 $12.9 Million
Q1 2020 May 07, 2020	SELL	$27.03 - $38.62 $300,249 - $428,990	-11,108 Reduced 2.69%	402,073 $13.1 Million
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $1.53 Million - $1.73 Million	46,390 Added 12.65%	413,181 $16.2 Million
Q3 2019 Oct 25, 2019	SELL	$32.49 - $42.13 $1.85 Million - $2.4 Million	-57,064 Reduced 13.46%	366,791 $13.2 Million
Q2 2019 Aug 01, 2019	SELL	$36.98 - $41.52 $9.36 Million - $10.5 Million	-253,105 Reduced 37.39%	423,855 $18.4 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $1.48 Million - $1.63 Million	-39,469 Reduced 5.51%	676,960 $28.8 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $474,912 - $541,451	-12,345 Reduced 1.69%	716,429 $31.3 Million
Q3 2018 Oct 31, 2018	SELL	$34.47 - $41.81 $866,886 - $1.05 Million	-25,149 Reduced 3.34%	728,774 $32.1 Million
Q2 2018 Aug 07, 2018	SELL	$32.98 - $35.16 $2.1 Million - $2.24 Million	-63,621 Reduced 7.78%	753,923 $27.4 Million
Q1 2018 May 09, 2018	BUY	$31.91 - $37.02 $1.44 Million - $1.67 Million	45,167 Added 5.85%	817,544 $29 Million
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $58,936 - $62,533	1,772 Added 0.23%	772,377 $28 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $23.9 Million - $26.3 Million	770,605	770,605 $27.5 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Capital Advisors LLC with notifications on news.

Account

Anchor Capital Advisors LLC Pfizer Inc Transaction History